The Carlyle Group, the investment company that bought one of Long Island's largest employers -- the vitamin maker NBTY Inc. -- has now decided to go public and has filed paperwork for an initial public offering.
The Washington, D.C.-based Carlyle Group bought NBTY, of Ronkonkoma, for $3.8 billion last year. NBTY had been a publicly traded company until, after the 2010 buy, Carlyle took it private.
NBTY, the maker of such well-known brands as Nature's Bounty, MET-Rx and Solgar nutritional supplements, has about 2,000 employees on Long Island, and about 14,000 worldwide. The company is the Island's sixth-largest in terms of sales.
The Carlyle IPO will be managed by J.P. Morgan Securities Llc, Citigroup Global Markets Inc. and Credit Suisse Securities (USA) Llc.
Photo: Supplements being manufactured at NBTY facilities in Bohemia. (Aug. 13, 2007)